Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD

Neurology

Volumn 57, Issue 3, 2001, Pages 560-561

  Savettieri, G ^a   De Marco, E V ^c   Civitelli, D ^c   Salemi, G ^a   Nicoletti, G ^c   Annesi, G ^c   Ciro Candiano I C ^c   Quattrone, A ^b,c,d  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c CNR   (Italy)

^d Policlinico Mater Domini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYDROLASE; LEVODOPA; PROTEIN UCHL1; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1; UNCLASSIFIED DRUG;

ACHL1 GENE; ADULT; AGED; ALLELISM; ARTICLE; BODY EQUILIBRIUM; BODY POSTURE; BRADYKINESIA; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; RISK ASSESSMENT; TREMOR;

EID: 0035859766     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.3.560     Document Type: Article

References (6)

1. The ubiquitin pathway in Parkinson's disease
2. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease
3. Ubiquitin C-terminal hydrolase L1 in sporadic Parkinson's disease
4. Mutation analysis and association studies of UCHLI gene in German Parkinson's disease patients
5. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease
6. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice